New Treatment for COVID-19 Using Ethanol Vapor Inhalation .
Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Since ARDS is a major complication of COVID - 19 with subsequent formation of non-cardiogenic
pulmonary edema , worsening the oxygenation of the patients and foamy and even bloody sputum
formation, so the idea is to use alcohol inhalation as it reduce surface tension on the
alveoli and markedly decrease sputum formation with improvement on oxygenation beside its
cytolethal effect on virus lipid bilayer.
A lot of researches and publications proved the role of alcohol inhalation in treatment of
pulmonary edema. Alcohol inhalation may has inflammatory effect and dangerous effect on
patients but this can be controlled by the actual concentration used and the way we use it
according to general condition of the patient and with the help of anti - inflammatory action
of Asprin .